Dipeptidyl peptidase inhibitors for the treatment of diabetes

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 417/06 (2006.01) A61K 31/38 (2006.01) A61K 31/395 (2006.01) A61K 31/40 (2006.01) A61K 31/426 (2006.01) A61K 31/427 (2006.01) A61K 38/55 (2006.01) A61K 45/00 (2006.01) C07D 207/16 (2006.01) C07D 207/26 (2006.01) C07D 207/46 (2006.01) C07D 277/06 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 409/06 (2006.01) C07D 413/12 (2006.01) C07D 417/12 (2006.01) C07D 521/00 (2006.01)

Patent

CA 2450579

Compounds having Formula I, including pharmaceutically acceptable salts and prodrugs thereof: (Formula I) are inhibitors of the dipep tidyl peptidase-IV enzyme (DP-IV), and are useful in the treatment of DP-IV mediated diseases and conditions, such as non-insulin dependent diabetes mellitus.

L'invention concerne des composés de formule (I), comprenant des sels pharmaceutiquement acceptables et des promédicaments pharmaceutiquement acceptables de ceux-ci. (I) Ces composés, qui inhibent l'enzyme dipeptidyle peptidase (DP-IV), s'avèrent utiles dans le traitement de maladies et d'états associés au DP-IV, tels que le diabète non insulino-dépendant.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dipeptidyl peptidase inhibitors for the treatment of diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dipeptidyl peptidase inhibitors for the treatment of diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dipeptidyl peptidase inhibitors for the treatment of diabetes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2059167

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.